[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
28/05/2024 15:10
{I-bank focus}UBS raises CSPC Pharma (01093) to HKD10.1
[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
Remark: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |